Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stephens

Showing results (881-890 of 1,072) with videos related to

Pageof 108
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancerStéphane Vignot, Garrett M Frampton, Jean-Charles Soria, et al.
JCO Precision Oncology|August 7, 2018
Genomic Profiling of T-Cell Neoplasms Reveals Frequent <i>JAK1</i> and <i>JAK3</i> Mutations With Clonal Evasion From Targeted TherapiesAllison Greenplate, Kai Wang, Rati M Tripathi, et al.
Cancer Research|February 26, 2017
High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer PathogenesisRyan J Hartmaier, Lee A Albacker, Juliann Chmielecki, et al.
Trials|March 19, 2025
Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trialAlexis Ogdie, Soumya M Reddy, Sarah H Gillespie, et al.
Pigment Cell & Melanoma Research|November 25, 2017
BRAF internal deletions and resistance to BRAF/MEK inhibitor therapyDouglas B Johnson, Merrida A Childress, Zachary R Chalmers, et al.
Oncoscience|August 6, 2015
Durable clinical benefit to trastuzumab and chemotherapy in a patient with metastatic colon adenocarcinoma harboring ERBB2 amplificationUmut Disel, Alexis Germain, Bahar Yilmazel, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2015
Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR-mutated NSCLC patients who had progressed on first- or second-generation EGFR TKISamuel J Klempner, Lyudmila A Bazhenova, Fadi S Braiteh, et al.
JAMA Network Open|October 31, 2023
Incidence, Microbiological Studies, and Factors Associated With Prosthetic Joint Infection After Total Knee ArthroplastyErica J Weinstein, Alisa J Stephens-Shields, Craig W Newcomb, et al.
Cancer|December 10, 2015
Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterationsJeffrey S Ross, Kai Wang, Depinder Khaira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancerDaniel J Sargent, Claus Henning Köhne, Hanna Kelly Sanoff, et al.
Pageof 108

Showing results (881-890 of 1,072) with videos related to

Sort By:
Pageof 108
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancerStéphane Vignot, Garrett M Frampton, Jean-Charles Soria, et al.
JCO Precision Oncology|August 7, 2018
Genomic Profiling of T-Cell Neoplasms Reveals Frequent <i>JAK1</i> and <i>JAK3</i> Mutations With Clonal Evasion From Targeted TherapiesAllison Greenplate, Kai Wang, Rati M Tripathi, et al.
Cancer Research|February 26, 2017
High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer PathogenesisRyan J Hartmaier, Lee A Albacker, Juliann Chmielecki, et al.
Trials|March 19, 2025
Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trialAlexis Ogdie, Soumya M Reddy, Sarah H Gillespie, et al.
Pigment Cell & Melanoma Research|November 25, 2017
BRAF internal deletions and resistance to BRAF/MEK inhibitor therapyDouglas B Johnson, Merrida A Childress, Zachary R Chalmers, et al.
Oncoscience|August 6, 2015
Durable clinical benefit to trastuzumab and chemotherapy in a patient with metastatic colon adenocarcinoma harboring ERBB2 amplificationUmut Disel, Alexis Germain, Bahar Yilmazel, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2015
Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR-mutated NSCLC patients who had progressed on first- or second-generation EGFR TKISamuel J Klempner, Lyudmila A Bazhenova, Fadi S Braiteh, et al.
JAMA Network Open|October 31, 2023
Incidence, Microbiological Studies, and Factors Associated With Prosthetic Joint Infection After Total Knee ArthroplastyErica J Weinstein, Alisa J Stephens-Shields, Craig W Newcomb, et al.
Cancer|December 10, 2015
Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterationsJeffrey S Ross, Kai Wang, Depinder Khaira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancerDaniel J Sargent, Claus Henning Köhne, Hanna Kelly Sanoff, et al.
Pageof 108